Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety of the long-term (1 year) coadministration of ezetimibe and atorvastatin
in participants with hypercholesterolemia who have not reached low density lipoprotein
(LDL)-cholesterol target with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase
inhibitors.